关键词: MADRS NMDA depression ketamine suicidality treatment‐resistant

来  源:   DOI:10.1002/ccr3.6675   PDF(Pubmed)

Abstract:
Numerous studies have demonstrated that low-dose subanesthetic intravenous ketamine infusion treatment leads to rapid improvement of treatment-resistant depression. The following case report describes the use of a very low-dose subcutaneous ketamine as a form of maintenance in a patient with severe treatment-resistant depression using a retrospective chart review.
摘要:
大量研究表明,低剂量亚麻醉药静脉输注氯胺酮治疗可快速改善难治性抑郁症。以下病例报告使用回顾性图表回顾,描述了使用极低剂量皮下氯胺酮作为严重难治性抑郁症患者的维持形式。
公众号